Skip to main content
. 2018 Mar 14;9(2):827–837. doi: 10.1007/s13300-018-0405-5

Fig. 3.

Fig. 3

Baseline-to-endpoint changes in basal insulin dose in patients with type 2 diabetes ≥ 65 and < 65 years. Data are least squares mean ± standard error. FBG fasting blood glucose, LOCF last observation carried forward, LY IGlar LY2963016 insulin glargine, SA IGlar insulin glargine